More research is needed to evaluate the effect of various chemotherapy regimens on survival in women with BRCA2-associated breast cancer, in particular with platinum-based regimens, which have shown preliminary evidence of effectiveness in BRCA1 mutation carriers.19–22. The gene discussed is BRCA1; the disease is breast cancer.